Pharmak

Farmak is a leading Ukrainian pharmaceutical company and a dominant player in the Eastern European healthcare sector. Established in 1925, the company has evolved from a chemical-pharmaceutical plant into a modern manufacturer with a diverse portfolio of over 400 medicinal products. Its core therapeutic focus includes endocrinology, cardiology, neurology, and ophthalmology, with a strong emphasis on high-quality generics and biosimilars. Farmak operates state-of-the-art production facilities that comply with international GMP standards and exports its products to more than 50 countries worldwide. The company is recognized for its significant investment in R&D, particularly in the development of complex injectable drugs and insulin products. Despite regional challenges, Farmak maintains a robust supply chain and continues to expand its international footprint through strategic partnerships and export growth.